Journal · Rheumatology · Updated 15 November 2026
Rheumatology
Read Rheumatology research on DeepDyve. No university library needed.
Rheumatology, published by Oxford University Press, covers clinical and laboratory research on diseases of the joints, muscles and connective tissue, and has appeared under its current title since 1999. Its papers range from rheumatoid arthritis and its treatments to systemic sclerosis, inflammatory muscle diseases and other autoimmune conditions. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Oxford University Press.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Rheumatology at a glance
- Full title
- Rheumatology
- Abbreviation (NLM)
- Rheumatology (Oxford)
- Publisher
- Oxford University Press
- Print ISSN
- 1462-0324
- Online ISSN (eISSN)
- 1462-0332
- Current title since
- 1999
- Subjects
- Rheumatology
- Access model
- Hybrid: subscription, with an open access option
- On DeepDyve
- Research articles; availability varies by article
Ways to access Rheumatology
18% of the articles Rheumatology published from January 1 to November 14, 2026 are open access and free to read. For the rest, check a library, look for NIH-funded papers in PubMed Central, or read them on DeepDyve.
- Open access articles. 18% of Rheumatology articles published from January 1 to November 14, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Rheumatology. Check its journal list and whether it offers remote access.
- DeepDyve. Read Rheumatology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: NIH Public Access Policy; open access share from Crossref license data.
Recent Rheumatology research worth reading
Published May to September 2026. Summaries describe what the authors report.
-
Effectiveness and safety of rituximab-pvvr versus originator rituximab for rheumatoid arthritis in the Veterans Health Administration
Comparing the biosimilar rituximab-pvvr with originator rituximab among 1,074 new users with rheumatoid arthritis in the Veterans Health Administration, the authors found no significant differences in effectiveness, such as stopping prednisone, or in safety, such as infection-related hospital or emergency visits.
Ghassemi et al. · Rheumatology, published online August 7, 2026 · DOI 10.1093/rheumatology/keag406
-
Ezetimibe/bempedoic acid combination in statin-induced anti-HMGCR-positive immune-mediated necrotizing myopathy: a case series
In six patients with statin-induced anti-HMGCR-positive necrotizing myopathy treated with ezetimibe plus bempedoic acid and followed for a median of 10 months, the authors report no relapses, stable muscle strength and creatine kinase, and mean LDL cholesterol falling from 133 to 82 mg/dl.
Lafaut et al. · Rheumatology, published online September 21, 2026 · DOI 10.1093/rheumatology/keag520
-
Synovial biopsy and tissue sampling in the management of RA
This review covers how synovial tissue biopsy in rheumatoid arthritis moved from blind needle and arthroscopic techniques to ultrasound-guided sampling, what histology and single-cell and spatial methods have revealed, and the R4RA and STRAP trials that tested treatment choices based on synovial biology.
Rheumatology, May 2026 · DOI 10.1093/rheumatology/keag241
-
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis
Analyzing an international study of systemic sclerosis, the authors found that higher telangiectasia counts on the face and hands were associated with calcinosis, digital ulcers and pulmonary arterial hypertension, and that patient and clinician counts agreed moderately for the face and forearms and less for the hands.
Rheumatology, May 2026 · DOI 10.1093/rheumatology/keag267
-
Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study
In a single-center cohort of 119 dermatomyositis patients, the authors report severe gastrointestinal involvement in 18% of those with anti-NXP2 antibodies, and in a 48-patient anti-NXP2 cohort it occurred in 12.5% and was associated with younger age and facial oedema at diagnosis.
Demuynck et al. · Rheumatology, published online June 17, 2026 · DOI 10.1093/rheumatology/keag282
Related journals
Questions about Rheumatology
How can I read Rheumatology articles without a subscription?
18% of Rheumatology articles published from January 1 to November 14, 2026 are open access and free to read. Your library may also subscribe. DeepDyve lets you read Rheumatology articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Rheumatology?
Rheumatology’s NLM (PubMed) abbreviation is Rheumatology (Oxford).
What is the ISSN of Rheumatology?
The print ISSN is 1462-0324 and the online ISSN is 1462-0332.
Is Rheumatology open access?
Rheumatology is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 14, 2026, 140 of 794 Rheumatology articles (18%) carry a Creative Commons license, per Crossref.
Rheumatology articles on DeepDyve are licensed from Oxford University Press. Journal facts as of 15 November 2026.
Start reading Rheumatology today
One month free, then less than $2 a day. Rheumatology, plus millions of articles from thousands of journals.





